Ganesh Subramanyam Palapattu MD
Ganesh S. Palapattu, MD, FACS joined the University of Michigan Department of Urology as Associate Professor and Chief of Urologic Oncology in the Fall of 2012. Prior to this he was the Chief of Urologic Oncology at The Methodist Hospital in Houston, Texas. Dr. Palapattu has held faculty appointments at the University of Rochester School of Medicine in Rochester, NY where he was also Assistant Residency Program Director and Weill Cornell Medical College/The Methodist Hospital.
Dr. Palapattu was born in Toronto, Canada where he developed a passion for street hockey. At the age of 9, his family moved to Houston, Texas where he picked up playing the French horn. Dr. Palapattu graduated from the University of Texas at Austin with a B.A. degree in the Humanities and subsequently attended Baylor College of Medicine. Dr. Palapattu received his surgical/urological training at UCLA and further specialty training in urologic oncology at Johns Hopkins. He and his wife, Anu, whom he met at UT Austin, have 2 young children. The Palapattu family is enthusiastic about taking advantage of the many outdoor activities the Ann Arbor area affords.
When not working, Dr. Palapattu enjoys spending time with his family- playing sports, building forts and generally having fun. He also likes to cross-train as well as watch professional and collegiate athletics- Go Blue!
- Baylor College of Medicine, 1997
- UCLA, Medical Center, Urology, CA, 2003
- American Urological Association
- Society of Urologic Oncology
- American Association for Cancer Research
- American Society of Clinical Oncology
- American College of Surgeons
As a surgeon-scientist, Dr. Palapattu maintains equal footing in the lab and clinic. The long term goal of his research program is to improve the outcomes of men with prostate cancer. Dr. Palapattu’s research seeks to shed new light on human prostate cancer stem cells, the prostate tumor microenvironment, mechanisms of prostate cancer progression, the biologic basis of prostate cancer health disparity, prostate cancer metabolism and improved methods of intra-operative prostate cancer and cavernous nerve imaging to aid surgical resection. His laboratory work has received funding from the National Cancer Institute (NCI), the Department of Defense, the Prostate Cancer Foundation and the New York Academy of Sciences, among others.